Paul Taylor

Paul Taylor, Princess Alexandra Hospital, Australia


Paul Taylor currently holds the position of Senior Scientist, Department of Clinical Pharmacology, Princess Alexandra Hospital, Brisbane, Australia. The focus of his research, over the past 15 years, has been on the application of LC-mass spectrometry to the clinical setting with emphasis on therapeutic drug monitoring, pharmacodynamic monitoring, biomarkers, assay development, and method validation. Paul’s current research has centred on the improved diagnosis of primary aldosteronism using LC-mass spectrometry, improved patient outcomes through individualisation of the newer immunosuppressant drugs and detection of the iron biomarker, hepcidin, by LC-mass spectrometry. Paul has published over 80 peer reviewed papers and 140 abstracts. Paul is an Editor of the Journal of Chromatography B and on the editorial board of Therapeutic Drug Monitoring. In 2003, he was awarded the International Association of Therapeutic Drug Monitoring and Clinical Toxicology “Young Investigator Award.”